Law360, New York (November 09, 2011, 6:12 PM ET) -- Merck & Co. Inc. on Tuesday said it had agreed to a $49.5 million settlement in a class action alleging its employees' savings plans took a hit from the company’s misrepresentations about the health risks associated with its former prescription painkiller Vioxx.
In a U.S. Securities and Exchange Commission filing, Merck said that it entered into the agreement with the plaintiffs on Aug. 16 in the consolidated Employee Retirement Income Security Act class action in New Jersey federal court.
"We're pleased to have reached a proposed...
Merck Settles ERISA Suit Over Vioxx Claims For $50M
To view the full article, take a free trial now.
